Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature - 2001-2007

BMC Health Services Research

Volumn 8, Issue , 2008, Pages

  Lu, Christine Y ^a   Ross Degnan, Dennis ^a   Soumerai, Stephen B ^a   Pearson, Sallie Anne ^b  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; STEROID;

ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; AUTOMATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG USE; EMBASE; HEALTH CARE; HEALTH CARE QUALITY; HELICOBACTER INFECTION; HUMAN; MANAGED CARE; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDLINE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT EDUCATION; PEPTIC ULCER; PHARMACIST; PSYCHOTHERAPY; PUBLICATION; SYSTEMATIC REVIEW; UNITED STATES; CLINICAL PRACTICE; DRUG UTILIZATION; HEALTH INSURANCE; INTERVENTION STUDY; PRACTICE GUIDELINE; PRESCRIPTION; STANDARD; STATISTICS;

DRUG UTILIZATION; GUIDELINE ADHERENCE; HUMANS; INTERVENTION STUDIES; MANAGED CARE PROGRAMS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTIONS, DRUG; QUALITY ASSURANCE, HEALTH CARE;

EID: 42449124605     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-8-75     Document Type: Article

References (87)

1. Trends and Indicators in the changing health care marketplace. Health Care Marketplace Project, Washington, DC, Henry J. Kaiser Family Foundation 2005 http://www.kff.org/insurance/7031/index.cfm
2. Prescription drug trends. Kaiser Family Foundation, Washington, DC, Henry J. Kaiser Family Foundation 2007 http://www.kff.org/rxdrugs/upload/3057_06.pdf
3. Effects of restrictive formularies in the ambulatory care setting. J Lexchin, American Journal of Managed Care 2002 8 69 76 11814174
4. The effects of prescription drug cost sharing: a review of the evidence. TB Gibson RJ Ozminkowski RZ Goetzel, American Journal of Managed Care 11:730-40, 2005
5. Employer Health Benefits: 2006 Annual Survey. Kaiser Family Foundation and the Health Research and Education Trust, Washington, DC, Henry J. Kaiser Family Foundation 2006 http://www.kff.org/insurance/7527/index.cfm
6. Changing medication use in managed care: a critical review of the available evidence. SA Pearson D Ross-Degnan A Payson SB Soumerai, American Journal of Managed Care 2003 9 715 731 14626470
7. Improving drug prescribing in primary care: A critical analysis of the experimental literature. SB Soumerai TS McLaughlin J Avorn, Milbank Q 1989 67 268 317 10.2307/3350142 2698446
8. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. SB Soumerai D Ross-Degnan EE Fortess J Abelson, Milbank Q 1993 71 217 252 10.2307/3350399 8510601
9. Printed educational materials: effects on professional practice and health care outcomes. N Freemantle EL Harvey F Wolf JM Grimshaw R Grilli LA Bero, Cochrane Database of Systematic Reviews (2):CD000172, 2000
10. Changing provider behavior: an overview of systematic reviews of interventions. JM Grimshaw L Shirran R Thomas G Mowatt C Fraser L Bero R Grilli E Harvey A Oxman MA O'Brien, Med Care 2001 8 II2 45
11. Pharmaceutical policies: effects on rational drug use, an overview of 13 reviews (Protocol). M Aaserud AT Dahlgren H Sturm JP Kösters S Hill CD Furberg R Grilli DA Henry AD Oxman C Ramsay D Ross-Degnan SB Soumerai, Cochrane Database of Systematic Reviews 2006 No.: CD004397
12. TD Cook DT Campbell, Quasi-Experimentation: Design & Analysis Issues for Field Settings Boston, Houghton Mifflin Company 1979
13. Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms. SR Majumdar D Ross-Degnan FA Farraye M Lee JA Kemp RF LeCates JM Henning SR Tunis P Schrammel SB Soumerai, Alimentary Pharmacology & Therapeutics 2005 21 1029 1039 10.1111/j.1365-2036.2005.02431.x 15813839
14. Principles of educational outreach ('academic detailing') to improve clinical decision making. SB Soumerai J Avorn, JAMA 1990 263 549 556 10.1001/jama.263.4.549 2104640
15. Educational outreach visits: effects on professional practice and health care outcomes. MA Thomson O'Brien AD Oxman DA Davis RB Haynes N Freemantle EL Harvey, Cochrane Database of Systematic Reviews (2):CD000409, 2000
16. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. SR Simon SR Majumdar LA Prosser S Salem-Schatz C Warner K Kleinman I Miroshnik SB Soumerai, American Journal of Medicine 2005 118 521 528 10.1016/j.amjmed.2004.12.023 15866255
17. Effects of ambulatory-care pharmacist consultation on mortality and hospitalization. Y Yuan JW Hay JS McCombs, American Journal of Managed Care 2003 9 45 56 12549814
18. Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. VJ Stevens RJ Shneidman RE Johnson M Boles PE Steele NL Lee, Western Journal of Medicine 2002 176 92 96 11897728
19. Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. SR Simon HP Rodriguez SR Majumdar K Kleinman C Warner S Salem-Schatz I Miroshnik SB Soumerai LA Prosser, Journal of Clinical Hypertension 2007 9 15 20 10.1111/j.1524-6175. 2007.07808.x 17215654
20. Does physician education on depression management improve treatment in primary care? EH Lin GE Simon DJ Katzelnick SD Pearson, Journal of General Internal Medicine 2001 16 617 619 10.1046/j.1525-1497.2001.016009614.x
21. Changes in antibiotic prescribing for children after a community-wide campaign. JF Perz AS Craig CS Coffey DM Jorgensen E Mitchel S Hall W Schaffner MR Griffin, JAMA 2002 287 3103 3109 10.1001/jama.287.23.3103 12069673
22. Audit and feedback: effects on professional practice and health care outcomes. G Jamtvedt JM Young DT Kristoffersen MA O'Brien AD Oxman, Cochrane Database of Systematic Reviews (2):CD000259, 2006
23. Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. G Jamtvedt JM Young DT Kristoffersen MA O'Brien AD Oxman, Quality & Safety in Health Care 2006 15 433 436 10.1136/qshc.2006.018549 17142594
24. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial. DC Goff Jr. L Gu LK Cantley DJ Sheedy SJ Cohen, American Heart Journal 2003 146 1045 1051 10.1016/S0002-8703(03)00522-2 14660997
25. Failure of Internet-based audit and feedback to improve quality of care delivered by primary care residents. SR Simon SB Soumerai, International Journal for Quality in Health Care 2005 17 427 431 10.1093/intqhc/mzi044 15831542
26. Antibiotic treatment of acute respiratory tract infections in the elderly: effect of a multidimensional educational intervention. R Gonzales A Sauaia KK Corbett JH Maselli K Erbacher BA Leeman-Castillo CA Darr PM Houck, Journal of the American Geriatrics Society 2004 52 39 45 10.1111/j.1532-5415. 2004.52008.x 14687313
27. Impact of an antidepressant management program on medication adherence. L Hoffman J Enders J Luo R Segal J Pippins C Kimberlin, American Journal of Managed Care 2003 9 70 80 12549816
28. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. [Review]. R Kaushal KG Shojania DW Bates, Archives of Internal Medicine 2003 163 1409 1416 10.1001/archinte.163.12.1409 12824090
29. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. DH Smith N Perrin A Feldstein X Yang D Kuang SR Simon DF Sittig R Platt SB Soumerai, Archives of Internal Medicine 2006 166 1098 1104 10.1001/archinte.166.10.1098 16717172
30. Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. A Feldstein PJ Elmer DH Smith M Herson E Orwoll C Chen M Aickin MC Swain, Journal of the American Geriatrics Society 2006 54 450 457 10.1111/j.1532-5415.2005.00618.x 16551312
31. Reducing warfarin medication interactions: an interrupted time series evaluation. AC Feldstein DH Smith N Perrin X Yang SR Simon M Krall DF Sittig D Ditmer R Platt SB Soumerai, Archives of Internal Medicine 2006 166 1009 1015 10.1001/archinte.166.9.1009 16682575
32. Computerized prescribing alerts and group academic detailing to reduce the use of potentially inappropriate medications in older people. SR Simon DH Smith AC Feldstein N Perrin X Yang Y Zhou R Platt SB Soumerai, Journal of the American Geriatrics Society 2006 54 963 968 10.1111/j.1532-5415.2006.00734.x 16776793
33. Physician alerts to increase antidepressant adherence: fax or fiction? KZ Bambauer AS Adams F Zhang N Minkoff A Grande R Weisblatt SB Soumerai D Ross-Degnan, Archives of Internal Medicine 2006 166 498 504 10.1001/archinte. 166.5.498 16534035
34. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. MA Raebel EE Lyons EA Chester MA Bodily JA Kelleher CL Long C Miller DJ Magid, Archives of Internal Medicine 2005 165 2395 2401 10.1001/archinte.165.20.2395 16287769
35. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. MA Raebel EA Chester EE Newsom EE Lyons JA Kelleher C Long C Miller DJ Magid, Pharmacotherapy 2006 26 619 626 10.1592/phco.26.5.619 16637791
36. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. TE Palen M Raebel E Lyons DM Magid, American Journal of Managed Care 2006 12 389 395 16834525
37. Improved therapeutic monitoring with several interventions: a randomized trial. AC Feldstein DH Smith N Perrin X Yang M Rix MA Raebel DJ Magid SR Simon SB Soumerai, Archives of Internal Medicine 2006 166 1848 1854 10.1001/archinte.166.17.1848 17000941
38. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. NM Rickles BL Svarstad JL Statz-Paynter LV Taylor KA Kobak, Journal of the American Pharmacists Association: JAPhA 45(3):344-53, 2005 Jun
39. Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies. NM Rickles BL Svarstad JL Statz-Paynter LV Taylor KA Kobak, Journal of the American Pharmacists Association: JAPhA 46(1):25-32, 2006 Feb
40. Use and impact of an automated telephone outreach system for asthma in a managed care setting. WM Vollmer M Kirshner D Peters A Drane T Stibolt T Hickey GI Tom AS Buist EA O'Connor EA Frazier D Mosen, American Journal of Managed Care 2006 12 725 733 17149995
41. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. AM Fendrick DG Smith ME Chernew SN Shah, American Journal of Managed Care 2001 7 861 867 11570020
42. The effect of incentive-based formularies on prescription-drug utilization and spending. HA Huskamp PA Deverka AM Epstein RS Epstein KA McGuigan RG Frank, N Eng J Med 2003 349 2224 2232 10.1056/NEJMsa030954
43. Impact of 3-tier formularies on drug treatment of attention-deficit/ hyperactivity disorder in children. HA Huskamp PA Deverka AM Epstein RS Epstein KA McGuigan AC Muriel RG Frank, Archives of General Psychiatry 2005 62 435 441 15809411 10.1001/archpsyc.62.4.435
44. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. B Motheral KA Fairman, Med Care 2001 39 1293 1304 10.1097/00005650-200112000-00005 11717571
45. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. KA Fairman BR Motheral RR Henderson, Clinical Therapeutics 2003 25 3147 3161 10.1016/S0149-2918(03)90099-3 14749153
46. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. KV Nair P Wolfe RJ Valuck MM McCollum JM Ganther SJ Lewis, Journal of Managed Care Pharmacy 2003 9 123 133 14613341
47. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? DW Roblin R Platt MJ Goodman J Hsu WW Nelson DH Smith SE Andrade SB Soumerai, Med Care 2005 43 951 959 10.1097/01.mlr.0000178216.23514.b7 16166864
48. Prior authorization programs: a critical review of the literature. NJ MacKinnon R Kumar, Journal of Managed Care Pharm 2001 7 297 302
49. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. DM Hartung DR Touchette KL Ketchum DG Haxby BW Goldberg, Clinical Therapeutics 2004 26 1518 1532 10.1016/j.clinthera.2004.09.013 15531015
50. Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program. PP Gleason C Williams S Hrdy SC Hartwig D Lassen, Pharmacotherapy 2005 25 924 934 10.1592/phco.2005.25. 7.924 16006271
51. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products. JH Gurwitz TJ McLaughlin LS Fish, Health Serv Res 1995 30 672 685 8537226
52. Enalapril to lisinopril: economic impact of a voluntary angiotensin-converting enzyme-inhibitor substitution program in a staff-model health maintenance organization. KP McDonough RH Weaver GD Viall, Ann Pharmacother 1992 26 399 404 1313320
53. Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting. SE Andrade JH Gurwitz J Cernieux LS Fish, Med Care 2000 38 970 975 10.1097/00005650-200009000-00010 10982118
54. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. PW Sullivan KV Nair BV Patel, American Journal of Managed Care 2005 11 374 382 15974556
55. Randomized controlled trial of a dose consolidation program. T Delate KA Fairman SM Carey BR Motheral, Journal of Managed Care Pharmacy 2004 10 396 403 15369422
56. Effect of patient notification of formulary change on formulary adherence. T Delate R Henderson, Journal of Managed Care Pharmacy 2005 11 493 498 15998166
57. Promoting use of a preferred histamine H2-receptor antagonist in managed care organizations. K DeZearn S Springer D Benson C Stephens, Am J Health Syst Pharm 1996 53 865 867 8728383
58. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. S Gilbody P Bower J Fletcher D Richards AJ Sutton, Archives of Internal Medicine 2006 166 2314 2321 10.1001/archinte.166.21.2314 17130383
59. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. PR Finley HR Rens JT Pont SL Gess C Louie SA Bull JY Lee LA Bero, Pharmacotherapy 2003 23 1175 1185 10.1592/phco.23.10.1175.32760 14524649
60. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. MP Okamoto RK Nakahiro, Pharmacotherapy 2001 21 1337 1344 10.1592/phco.21.17. 1337.34424 11714206
61. Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease. TF Rehring RS Stolcpart BG Sandhoff JA Merenich HW Hollis Jr., Journal of Vascular Surgery 2006 43 1205 1210 10.1016/j.jvs.2006.02. 019 16765240
62. Achieving cholesterol target in a managed care organization (ACTION) trial. RJ Straka R Taheri SL Cooper JC Smith, Pharmacotherapy 2005 25 360 371 10.1592/phco.25.3.360.61601 15843283
63. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. JE Borenstein G Graber E Saltiel J Wallace S Ryu J Archi S Deutsch SR Weingarten, Pharmacotherapy 2003 23 209 216 10.1592/phco.23.2.209. 32096 12587810
64. Disease management in the American market. T Bodenheimer, BMJ 2000 320 563 566 10688566 10.1136/bmj.320.7234.563
65. Effectiveness of disease management programs in depression: a systematic review. E Badamgarav SR Weingarten JM Henning K Knight V Hasselblad A Gano Jr. JJ Ofman, American Journal of Psychiatry 2003 160 2080 2090 10.1176/appi.ajp. 160.12.2080 14638573
66. The costs of depression: direct and indirect; treatment versus nontreatment. [Review]. PJ Panzarino Jr., Journal of Clinical Psychiatry 1920 59 11 14
67. Long-term effects of a collaborative care intervention in persistently depressed primary care patients. W Katon J Russo M Von Korff E Lin G Simon T Bush E Ludman E Walker, Journal of General Internal Medicine 2002 17 741 748 12390549 10.1046/j.1525-1497.2002.11051.x
68. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. WJ Katon M Von Korff EH Lin G Simon E Ludman J Russo P Ciechanowski E Walker T Bush, Archives of General Psychiatry 2004 61 1042 1049 10.1001/archpsyc.61.10.1042 15466678
69. Two-year effects of quality improvement programs on medication management for depression. J Unutzer L Rubenstein WJ Katon L Tang N Duan IT Lagomasino KB Wells, Archives of General Psychiatry 2001 58 935 942 10.1001/archpsyc.58.10.935 11576031
70. Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy. WA Ray JR Daugherty KG Meador, N Eng J Med 2003 348 1885 1894 10.1056/NEJMsa020584
71. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. P Lozano JA Finkelstein VJ Carey EH Wagner TS Inui AL Fuhlbrigge SB Soumerai SD Sullivan ST Weiss KB Weiss, Archives of Pediatrics & Adolescent Medicine 2004 158 875 883 10.1001/archpedi.158.9.875 15351753
72. Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team. JA Finkelstein P Lozano AL Fuhlbrigge VJ Carey TS Inui SB Soumerai SD Sullivan EH Wagner ST Weiss KB Weiss Pediatric Asthma Care Patient Outcomes Research Team, Health Serv Res 2005 40 1737 1757 16336546 10.1111/j.1475-6773.2005.00451.x
73. Helicobacter pylori-related disease: guidelines for testing and treatment. WL Peterson AM Fendrick DR Cave DA Peura SM Garabedian-Ruffalo L Laine, Archives of Internal Medicine 2000 160 1285 1291 10.1001/archinte.160.9. 1285 10809031
74. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.[erratum appears in JAMA 1996 May 1;275(17):1314]. AH Soll, JAMA 1996 275 622 629 10.1001/jama.275.8.622 8594244
75. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. JE Allison LB Hurley RA Hiatt TR Levin LM Ackerson TA Lieu, Archives of Internal Medicine 2003 163 1165 1171 10.1001/archinte.163.10.1165 12767952
76. A randomized trial of an acid-peptic disease management program in a managed care environment. JJ Ofman R Segal WL Russell DJ Cook M Sandhu SK Maue EH Lowenstein R Pourfarzib E Blanchette G Ellrodt SR Weingarten, American Journal of Managed Care 9(6):425-33, 2003
77. Adherence to medication. L Osterberg T Blaschke, New England Journal of Medicine 353(5):487-97, 2005
78. Interventions to improve antibiotic prescribing practices in ambulatory care. SR Arnold SE Straus, Cochrane Database of Systematic Reviews (4):CD003539, 2005
79. Local opinion leaders: effects on professional practice and health care outcomes. [Review]. MA Thomson O'Brien AD Oxman RB Haynes DA Davis N Freemantle EL Harvey, Cochrane Database of Systematic Reviews (2):CD000125, 2000
80. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. GE Simon M VonKorff C Rutter E Wagner, BMJ 2000 320 550 554 10688563 10.1136/bmj.320.7234. 550
81. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. [Review]. K Kawamoto CA Houlihan EA Balas DF Lobach, BMJ 2005 330 765 15767266 10.1136/bmj.38398.500764.8F
82. Are incentive-based formularies inversely associated with drug utilization in managed care? PP Gleason BW Gunderson KR Gericke, Ann Pharmacother 2005 39 339 345 10.1345/aph.1E380 15644478
83. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. SB Soumerai, Health Affairs 2004 23 135 146 10.1377/hlthaff.23.1. 135 15002636
84. Evaluating the impact of pharmacists in mental health: a systematic review. PR Finley ML Crismon AJ Rush, Pharmacotherapy 2003 23 1634 1644 10.1592/phco.23.15.1634.31952 14695043
85. Clinical pharmacists and inpatient medical care: a systematic review. [Review]. PJ Kaboli AB Hoth BJ McClimon JL Schnipper, Archives of Internal Medicine 2006 166 955 964 10.1001/archinte.166.9.955 16682568
86. Improving adherence to antidepressants: a systematic review of interventions. [Review]. AC Vergouwen A Bakker WJ Katon TJ Verheij F Koerselman, Journal of Clinical Psychiatry 2003 64 1415 1420 14728101
87. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports.[Review]. SR Weingarten JM Henning E Badamgarav K Knight V Hasselblad A Gano Jr. JJ Ofman, BMJ 2002 325 925 12399340 10.1136/bmj.325.7370.925